Fig. 2

Lung targeting assessment of AA/γCD. (A) Organ concentration of inclusion cocrystal AA/γCD in plasma, heart, liver, spleen, lung, and kidney at 0.25 h, 0.5 h, 1 h, and 2 h after intravenous injection (in vivo). Dose: 10 mg/kg. (B) The hemolysis effect of AA/γCD cocrystal in 0.1–0.5 mg/mL. (C) HE staining of lung sections after three consecutive injections of AA/γCD cocrystals (10 mg/kg)